Skip to content
777 Sourcing.

Capability

bacterial outer membrane vesicle (OMV) platform

Suppliers
1
States & provinces
1
Countries
1

1 bacterial outer membrane vesicle (omv) platform supplier across 1 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

IRAZU ONCOLOGY LLC

WILMINGTON, DE

Irazu Oncology, LLC is a clinical-stage biotech founded in 2022 developing off-the-shelf cancer immunotherapies built on a proprietary bacterial outer membrane vesicle (OMV) platform. The platform creates customized, self-adjuvanted mono/multivalent therapeutic vaccines carrying tumor antigens and immune-activating signals. Its lead program, IRZ-03, is a first-in-class multimodal OMV immunotherapy targeting CEA, MUC1, and PD-L1 for checkpoint inhibitor-refractory solid tumors.

IND-enabling studiesscalable bacterial fermentationvaccine development

Compiled from public sources

Related capabilities

Other processes offered by the shops that list bacterial outer membrane vesicle (OMV) platform.

Browse all capabilities